Evidence map›Paper›PMID 30807577›Full record

ArticlePloS one2019

RETRACTED: Impact of miR-223-3p and miR-2909 on inflammatory factors IL-6, IL-1ß, and TNF-α, and the TLR4/TLR2/NF-κB/STAT3 signaling pathway induced by lipopolysaccharide in human adipose stem cells.

Juan Wu, Ping Niu, Yueqiang Zhao, Yanyang Cheng, Weiping Chen, Lan Lin, Jingmei Lu, Xue Cheng, Zhiliang Xu

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Effect of Enteric-Derived Lipopolysaccharides on Obesity.International journal of molecular sciences · 2024
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Juan WuDepartment of Pediatrics, Ren Min Hospital of Wuhan University, WuHan, People's Republic of China.
Ping NiuDepartment of Pediatrics, Ren Min Hospital of Wuhan University, WuHan, People's Republic of China.
Yueqiang ZhaoDepartment of Pediatrics, Ren Min Hospital of Wuhan University, WuHan, People's Republic of China.
Yanyang ChengDepartment of Pediatrics, Ren Min Hospital of Wuhan University, WuHan, People's Republic of China.
Weiping ChenDepartment of Pediatrics, Ren Min Hospital of Wuhan University, WuHan, People's Republic of China.
Lan LinDepartment of Pediatrics, Ren Min Hospital of Wuhan University, WuHan, People's Republic of China.
Jingmei LuDepartment of Pediatrics, Ren Min Hospital of Wuhan University, WuHan, People's Republic of China.
Xue ChengDepartment of Pediatrics, Ren Min Hospital of Wuhan University, WuHan, People's Republic of China.
Zhiliang XuDepartment of Pediatrics, Ren Min Hospital of Wuhan University, WuHan, People's Republic of China.ORCID 0000-0002-4227-1170
Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) are small non-coding RNA molecules that play an important role in the regulation of gene expression related to inflammatory responses. Human adipose stem cells are characterized by pluripotent differentiation potential and isolated from adipose tissues. These cells regulate inflammation mainly by interacting with immune cells and affecting the secretion of immune factors; details of this interaction are currently unknown. In the current study, we successfully established an acute inflammation model and a chronic inflammation model involving adipose stem cells. We used high-throughput miRNA microarray analysis to identify miRNAs that were significantly (p < 0.05) differentially expressed during both acute and chronic inflammation. Lipopolysaccharide (LPS) significantly (p < 0.05) reduced the expression of miR-223-3P and miR-2909, while promoting the production of pro-inflammatory cytokines, interleukin (IL) 6, IL-1β, and tumor necrosis factor (TNF)-α via the Toll-like receptor (TLR) 4/TLR2/nuclear factor (NF)-κB/signal transducer and activator of transcription (STAT) 3 signaling pathway in human adipose stem cells. Further, miR-223-3P expression was significantly (p < 0.05) reduced in human adipose stem cells during activation by IL-6 stimulation. The inducible down-regulation of miR-223-3P resulted in the activation of STAT3, which was directly targeted by miR-223-3P. STAT3 directly targeted TLR4 and TLR2, promoting the production of the pro-inflammatory cytokine, IL-6, and formed a positive feedback loop to regulate IL-6 levels. Similarly, TNF-α significantly (p < 0.05) increased the expression of miR-223-3p, with LPS and TLR4/TLR2/NF-κB/STAT3 forming a negative feedback loop to regulate TNF-α levels. In addition, miR-2909, which depends on NF-κB, targeted Krueppel-like factor (KLF) 4 to regulate the levels of pro-inflammatory cytokines, IL-6, IL-1β, and TNF-α. We conclude that miR-223-3p and miR-2909 form a complex regulatory network with pro-inflammatory factors and signaling pathways in adipose stem cells stimulated by LPS. These findings will inform the development of therapies against autoimmune and inflammatory diseases.

Indexed as

Adipose TissueAntagomirsCell SurvivalHumansInterleukin-1betaInterleukin-6Interleukin-6 InhibitorsLipopolysaccharidesMicroRNAsNF-kappa BPhosphorylationRNA InterferenceRNA, Small InterferingSignal TransductionSTAT3 Transcription FactorStem CellsAntagomirsInterleukin-1betaInterleukin-6Interleukin-6 InhibitorsLipopolysaccharidesMicroRNAsMIR223, humanMIRN2909 microRNA, humanNF-kappa BRNA, Small InterferingSTAT3 Transcription FactorToll-Like Receptor 2Toll-Like Receptor 4Tumor Necrosis Factor-alpha

Identifiers

PMID30807577
PMCPMC6391004
OpenAlexW2915302836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.